Anti-CSF-1R emactuzumab in combination with anti-PD-L1 atezolizumab in advanced solid tumor patients naïve or experienced for immune checkpoint blockade

  1. Gomez-Roca, C.
  2. Cassier, P.
  3. Zamarin, D.
  4. Machiels, J.-P.
  5. Luis Perez Gracia, J.
  6. Stephen Hodi, F.
  7. Taus, A.
  8. Martinez Garcia, M.
  9. Boni, V.
  10. Eder, J.P.
  11. Hafez, N.
  12. Sullivan, R.
  13. Mcdermott, D.
  14. Champiat, S.
  15. Aspeslagh, S.
  16. Terret, C.
  17. Jegg, A.-M.
  18. Jacob, W.
  19. Cannarile, M.A.
  20. Ries, C.
  21. Korski, K.
  22. Michielin, F.
  23. Christen, R.
  24. Babitzki, G.
  25. Watson, C.
  26. Meneses-Lorente, G.
  27. Weisser, M.
  28. Rüttinger, D.
  29. Delord, J.-P.
  30. Marabelle, A.
  31. Montrer des auteurs +
Revue:
Journal for immunotherapy of cancer

ISSN: 2051-1426

Année de publication: 2022

Volumen: 10

Número: 5

Type: Article

DOI: 10.1136/JITC-2021-004076 GOOGLE SCHOLAR lock_openAccès ouvert editor

Objectifs de Développement Durable

La source de données: Scopus